TELA Bio, Inc. Research and Development Expense
TELA Bio, Inc. (TELA) reported Research and Development Expense of $2.72 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-11
- TELA Bio, Inc. research and development expense for the quarter ending 2026-06-30 was $2.72M, a 23.60% increase year-over-year.
- TELA Bio, Inc. research and development expense for the quarter ending 2026-03-31 was $2.34M, a 7.76% decline year-over-year.
- TELA Bio, Inc. research and development expense for the quarter ending 2025-12-31 was $2.13M, a 4.93% increase year-over-year.
- TELA Bio, Inc. research and development expense for the quarter ending 2025-09-30 was $2.35M, a 13.54% increase year-over-year.
- TELA Bio, Inc. research and development expense for fiscal 2025 was $9.22M, a 4.62% increase from fiscal 2024.
- TELA Bio, Inc. research and development expense for fiscal 2024 was $8.81M, a 8.38% decline from fiscal 2023.
- TELA Bio, Inc. research and development expense for fiscal 2023 was $9.62M, a 7.63% increase from fiscal 2022.
- TELA Bio, Inc. research and development expense for fiscal 2022 was $8.94M, a 32.54% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.72M 10-Q · filed 2026-08-11 | $5.07M 10-Q · filed 2026-08-11 | $7.20M derived: sum of 3 quarters · filed 2026-08-11 | $9.54M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $2.34M 10-Q · filed 2026-05-13 | $4.47M derived: sum of 2 quarters · filed 2026-05-13 | $6.82M derived: sum of 3 quarters · filed 2026-05-13 | $9.02M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $4.48M derived: sum of 2 quarters · filed 2026-03-25 | $6.68M derived: sum of 3 quarters · filed 2026-08-11 | $9.22M 10-K · filed 2026-03-25 |
| 2025-09-30 | $2.35M 10-Q · filed 2025-11-14 | $4.55M derived: sum of 2 quarters · filed 2026-08-11 | $7.09M 10-Q · filed 2025-11-14 | $9.12M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $2.20M 10-Q · filed 2026-08-11 | $4.74M 10-Q · filed 2026-08-11 | $6.77M derived: sum of 3 quarters · filed 2026-08-11 | $8.84M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $2.54M 10-Q · filed 2026-05-13 | $4.57M derived: sum of 2 quarters · filed 2026-05-13 | $6.64M derived: sum of 3 quarters · filed 2026-05-13 | $8.96M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $2.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $4.10M derived: sum of 2 quarters · filed 2026-03-25 | $6.42M derived: sum of 3 quarters · filed 2026-03-25 | $8.81M 10-K · filed 2026-03-25 |
| 2024-09-30 | $2.07M 10-Q · filed 2025-11-14 | $4.39M derived: sum of 2 quarters · filed 2025-11-14 | $6.78M 10-Q · filed 2025-11-14 | $9.47M derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-06-30 | $2.32M 10-Q · filed 2025-08-11 | $4.72M 10-Q · filed 2025-08-11 | $7.40M derived: sum of 3 quarters · filed 2026-03-25 | $9.77M derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-03-31 | $2.39M 10-Q · filed 2025-05-08 | $5.08M derived: sum of 2 quarters · filed 2026-03-25 | $7.45M derived: sum of 3 quarters · filed 2026-03-25 | $9.96M derived: sum of 4 quarters · filed 2026-03-25 |
| 2023-12-31 | $2.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $5.05M derived: sum of 2 quarters · filed 2026-03-25 | $7.57M derived: sum of 3 quarters · filed 2026-03-25 | $9.62M 10-K · filed 2026-03-25 |
| 2023-09-30 | $2.37M 10-Q · filed 2024-11-08 | $4.88M derived: sum of 2 quarters · filed 2024-11-08 | $6.93M 10-Q · filed 2024-11-08 | $9.66M derived: sum of 4 quarters · filed 2025-03-21 |
| 2023-06-30 | $2.51M 10-Q · filed 2024-08-13 | $4.57M 10-Q · filed 2024-08-13 | $7.29M derived: sum of 3 quarters · filed 2025-03-21 | $9.39M derived: sum of 4 quarters · filed 2025-03-21 |
| 2023-03-31 | $2.05M 10-Q · filed 2024-05-10 | $4.78M derived: sum of 2 quarters · filed 2025-03-21 | $6.88M derived: sum of 3 quarters · filed 2025-03-21 | $8.98M derived: sum of 4 quarters · filed 2025-03-21 |
| 2022-12-31 | $2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $4.83M derived: sum of 2 quarters · filed 2025-03-21 | $6.93M derived: sum of 3 quarters · filed 2025-03-21 | $8.94M 10-K · filed 2025-03-21 |
| 2022-09-30 | $2.10M 10-Q · filed 2023-11-13 | $4.20M derived: sum of 2 quarters · filed 2023-11-13 | $6.21M 10-Q · filed 2023-11-13 | $7.94M derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-06-30 | $2.10M 10-Q · filed 2023-08-10 | $4.11M 10-Q · filed 2023-08-10 | $5.83M derived: sum of 3 quarters · filed 2024-03-22 | $7.24M derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-03-31 | $2.01M 10-Q · filed 2023-05-11 | $3.73M derived: sum of 2 quarters · filed 2024-03-22 | $5.14M derived: sum of 3 quarters · filed 2024-03-22 | $7.07M derived: sum of 4 quarters · filed 2024-03-22 |
| 2021-12-31 | $1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $3.13M derived: sum of 2 quarters · filed 2024-03-22 | $5.06M derived: sum of 3 quarters · filed 2024-03-22 | $6.74M 10-K · filed 2024-03-22 |
| 2021-09-30 | $1.41M 10-Q · filed 2022-11-10 | $3.34M derived: sum of 2 quarters · filed 2022-11-10 | $5.02M 10-Q · filed 2022-11-10 | $6.18M derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-06-30 | $1.93M 10-Q · filed 2022-08-11 | $3.61M 10-Q · filed 2022-08-11 | $4.77M derived: sum of 3 quarters · filed 2023-03-23 | $5.97M derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-03-31 | $1.68M 10-Q · filed 2022-05-11 | $2.84M derived: sum of 2 quarters · filed 2023-03-23 | $4.04M derived: sum of 3 quarters · filed 2023-03-23 | $5.02M derived: sum of 4 quarters · filed 2023-03-23 |
| 2020-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $2.36M derived: sum of 2 quarters · filed 2023-03-23 | $3.34M derived: sum of 3 quarters · filed 2023-03-23 | $4.25M 10-K · filed 2023-03-23 |
| 2020-09-30 | $1.20M 10-Q · filed 2021-11-12 | $2.18M derived: sum of 2 quarters · filed 2021-11-12 | $3.09M 10-Q · filed 2021-11-12 | $4.01M derived: sum of 4 quarters · filed 2022-03-23 |
| 2020-06-30 | $979.00K 10-Q · filed 2021-08-12 | $1.89M 10-Q · filed 2021-08-12 | $2.81M derived: sum of 3 quarters · filed 2022-03-23 | $3.33M derived: sum of 4 quarters · filed 2022-03-23 |
| 2020-03-31 | $912.00K 10-Q · filed 2021-05-14 | $1.83M derived: sum of 2 quarters · filed 2022-03-23 | $2.35M derived: sum of 3 quarters · filed 2022-03-23 | $3.40M derived: sum of 4 quarters · filed 2022-03-23 |
| 2019-12-31 | $921.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $1.44M derived: sum of 2 quarters · filed 2022-03-23 | $2.49M derived: sum of 3 quarters · filed 2022-03-23 | $4.15M 10-K · filed 2022-03-23 |
| 2019-09-30 | $516.00K 10-Q · filed 2020-11-12 | $1.57M derived: sum of 2 quarters · filed 2020-11-12 | $3.23M 10-Q · filed 2020-11-12 | $4.21M derived: sum of 4 quarters · filed 2021-03-25 |
| 2019-06-30 | $1.05M 10-Q · filed 2020-08-13 | $2.71M 10-Q · filed 2020-08-13 | $3.69M derived: sum of 3 quarters · filed 2021-03-25 | $4.74M derived: sum of 4 quarters · filed 2021-03-25 |
| 2019-03-31 | $1.66M 10-Q · filed 2020-05-15 | $2.64M derived: sum of 2 quarters · filed 2021-03-25 | $3.68M derived: sum of 3 quarters · filed 2021-03-25 | |
| 2018-12-31 | $977.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $2.02M derived: sum of 2 quarters · filed 2021-03-25 | $4.34M 10-K · filed 2021-03-25 | |
| 2018-09-30 | $1.04M 10-Q · filed 2019-12-18 | $3.36M 10-Q · filed 2019-12-18 | ||
| 2017-12-31 | $5.79M 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |